Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infections

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 1, 1999, Pages 73-78

  Jason, Janine ^a,d   Archibald, Lennox ^b   McDonald, L Clifford ^b   Hart, W Michael ^a   Rheanppumikankit, Sunthorn ^c   Tansuphwaswadikul, Somsit ^c   Byrd, Martha G ^a   Larned, Joshua ^a   Han, Alison ^a   Green, Timothy A ^a   Jarvis, William R ^b,e  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Bamrasnaradura Infectious Disease Institute   (Thailand)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PREDICTION; PRIORITY JOURNAL; THAILAND; TREATMENT OUTCOME;

EID: 0032924146     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.1.73-78.1999     Document Type: Article

References (31)

1. Archibald, L. K., M. O. den Dulk, K. J. Pallangyo, and L. B. Relier. 1998. Fatal mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults, Dar es Salaam, Tanzania. Clin. Infect. Dis. 26:290-296.
2. Bermudez, L. E. M., and L. S. Young. 1991. Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J. Immunol. 146:265-270.
3. Breen, E. C., J. F. Salazar-Gonzalez, L. P. Shen, J. A. Kolberg, M. S. Urdea, O. Martinez-Maza, and J. L. Fahey. 1997. Circulating CD8 T cells show increased interferon-gamma mRNA expression in HIV infection. Cell. Immunol. 178:91-98.
4. Caruso, A., A. D. Canaris, S. Licenziati, A. Cantalamessa, S. Folghera, M. A. Lonati, G. dePanfilis, G. Garotta, and A. Turano. 1995. CD4+ and CD8+ lymphocytes of patients with AIDS synthesize increased amounts of interferon-gamma. J. Acquired Immune Defic. Syndr. 10:462-470.
5. Clerici, M., and G. M. Shearer. 1993. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
6. Djeu, J. Y., M. B. Michelini-Norris, and D. K. Blanchard. 1994. Macrophage-natural killer cell interactions in resistance to mycobacteria. Immunol. Ser. 60:225-231.
7. Fresno, M., M. Kopf, and L. Rivas. 1997. Cytokines and infectious diseases. Immunol. Today 18:56-58.
8. Harrison, T. S., S.-H. Nong, and S. M. Levitz. 1997. Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans. J. Infect. Dis. 176:485-491.
9. Jacobson, J. M., J. S. Greenspan, J. Spritzler, N. Ketter, J. L. Fahey, J. B. Jackson, L. Fox, G. J. Vasquez, and D. A. Wohl. 1997. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. N. Engl. J. Med. 336:1487-1491.
10. Jason, J., L. A. Sleeper, S. M. Donfield, J. Murphy, I. Warrier, S. Arkin, and B. Evatt. 1995. Evidence for a shift from a type I lymphocyte pattern with HIV disease progression. J. Acquired Immune Defic. Syndr. 10:471-476.
11. Jason, J., and J. Larned. 1997. Single-cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols. J. Immunol. Methods 207:13-22.
12. Jassoy, C., T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, and R. P. Johnson. 1993. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma Interferon, tumor necrosis factor alpha (TNF-α), and TNF-β when they encounter their target antigens. J. Virol. 67:2844-2852.
13. Keller, R., R. Keist, and P. Joller. 1995. Macrophage response to microbial pathogens: modulation of the expression of adhesion, CD14, and MHC class II molecules by viruses, bacteria, protozoa and fungi. Scand. J. Immunol. 42: 337-344.
14. Klausner, J. D., S. Makonkawkeyoon, P. Akarasewi, K. Nakata, W. Kasinrerk, L. Corral, R. L. Dewar, H. C. Lane, V. H. Freedman, and G. Kaplan. 1996. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11:247-257.
15. Koziel, M. J., D. Dudley, N. Afdhal, A. Grakoui, C. M. Rice, Q. L. Choo, M. Houghton, and B. D, Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:2311-2321. f
16. Kragsbjerg, P., H. Holmberg, and T. Vikerfors. 1996. Dynamics of. blood cytokine concentrations in patients with bacteremic infections. Scand. J. Infect. Dis. 28:391-398.
17. Lorgat, F., M. M. Keraan, P. T. Lukey, and S. R. Ress. 1992. Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tu-berculous pleural effusions demonstrate enhanced cytotoxicity with acceler-ated kinetics of induction. Am. Rev. Respir. Dis. 145:418-423.
18. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. de Carli, M. P. Piccinni, R. Manetti, M. Carbonari, A. M. Pesce, G. del Prete, and S. Romagnani. 1994. Ability of HIV to promote a ThI to ThO shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244-248.
19. Matsuyama, T., N. Kobayashi, and N. Yaniamoto. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5:1405-1417.
20. Mossmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coflman. 1986. Two types of murine helper T cell clones. I. Definition according to profiles of lyrnphofcine activities and secreted proteins. J. Im-munol. 136:2348-2357.
21. Mossmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: ThI, Th2, and more. Immunol. Today 17:138-146.
22. Rom, W. N., N. Schluger, K. Law, R. Condos, Y. Zhang, M. Weiden, T. Harkin, and K.-M. Tchou-Wong. 1995. Human host response to Mycobac-lerium tuberculosis. Schweiz. Med. Wochenschr. 125:2178-2185.
23. Rook, G. A. W. 1994. Macrophages and Mycobacterium tuberculosis: the key to pathogenesis. Immunol. Ser. 60:249-261.
24. Sander, B., J. Andersson, and U. Andersson. 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunolog. Rev. 119:65-93.
25. Savedra, R., Jr., R. L. Delude, R. R. Ingalls, M. J. Fenton, and D. T. Golenbock. 1996. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J. Im-munol. 157:2549-2554.
26. Selik, R. M., J. M. Karon, and J. W. Ward. 1997. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J. Infect. Dis. 176:632-636.
27. Shirahata, T., T. Yamnashita, C. Ohta, H. Goto, and A. Nakane. 1994. CD8+ T lymphocytes are the major cell population involved in the earlv gamma Interferon response and resistance to acute primary Toxoplasma gondii infection in mice. Microbiol. Immunol. 38:789-796.
28. Swain, S. L. 1995. T-cell subsets. Who does the polarizing? Curr. Biol. 5:849-851.
29. Tambussi, G., V. Albarello, A. Gori, C. Bisson, and A. Lazzarin. 1994. Transitory expansion of a CD3+TcR gamma/delta + CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activity. AIDS Res. Hum. Retro-viruses 10:711-715.
30. Wallis, R. S., and J. J. Ellner. 1994. Cytokines and tuberculosis. J. Leukocyte Biol. 55:676-681.
31. Weinstein, M. P. 1996. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin. Infect. Dis. 23:40-46.